169 related articles for article (PubMed ID: 33361026)
1. Effect of dexmedetomidine and cholinergic anti-inflammatory pathways in myocardial ischemia-reperfusion injury.
Ju Y; Xiao F; Lu J; Zhou B; Cai J; Chen S
Pak J Pharm Sci; 2020 May; 33(3(Special)):1377-1382. PubMed ID: 33361026
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury.
Zhang J; Xia F; Zhao H; Peng K; Liu H; Meng X; Chen C; Ji F
PLoS One; 2019; 14(7):e0218726. PubMed ID: 31344138
[TBL] [Abstract][Full Text] [Related]
3. Arginase-2 protects myocardial ischemia-reperfusion injury via NF-κB/TNF-α pathway.
Huang XW; Pan MD; Du PH; Wang LX
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6529-6537. PubMed ID: 30338823
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.
Li J; Zhao Y; Zhou N; Li L; Li K
J Diabetes Res; 2019; 2019():7869318. PubMed ID: 31886285
[TBL] [Abstract][Full Text] [Related]
5. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
Zhang J; Jiang H; Liu DH; Wang GN
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
[TBL] [Abstract][Full Text] [Related]
6. Vagal stimulation mimics preconditioning and postconditioning of ischemic myocardium in mice by activating different protection mechanisms.
Buchholz B; Kelly J; Muñoz M; Bernatené EA; Méndez Diodati N; González Maglio DH; Dominici FP; Gelpi RJ
Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1289-H1297. PubMed ID: 29631370
[TBL] [Abstract][Full Text] [Related]
7. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.
Xiang H; Hu B; Li Z; Li J
Inflammation; 2014 Oct; 37(5):1763-70. PubMed ID: 24803295
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of N(2)‑L‑alanyl‑L‑glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion.
Liu S; Yang Y; Song YQ; Geng J; Chen QL
Mol Med Rep; 2018 Apr; 17(4):5102-5108. PubMed ID: 29393473
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine-Mediated Prevention of Renal Ischemia-Reperfusion Injury Depends in Part on Cholinergic Anti-Inflammatory Mechanisms.
Ma J; Chen Q; Li J; Zhao H; Mi E; Chen Y; Yi B; Ning J; Ma D; Lu K; Gu J
Anesth Analg; 2020 Apr; 130(4):1054-1062. PubMed ID: 30346356
[TBL] [Abstract][Full Text] [Related]
11. Vagal stimulation triggers peripheral vascular protection through the cholinergic anti-inflammatory pathway in a rat model of myocardial ischemia/reperfusion.
Zhao M; He X; Bi XY; Yu XJ; Gil Wier W; Zang WJ
Basic Res Cardiol; 2013 May; 108(3):345. PubMed ID: 23519622
[TBL] [Abstract][Full Text] [Related]
12. Magnesium lithospermate B reduces myocardial ischemia/reperfusion injury in rats via regulating the inflammation response.
Quan W; Wei G; Zhou D; Zhu Y; Guo C; Wang Y; Weng Y; Xi M; Wen A
Pharm Biol; 2013 Nov; 51(11):1355-62. PubMed ID: 23863120
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of α7nAChR and PI3K/Akt- mediated autophagy.
Yu T; Liu D; Gao M; Yang P; Zhang M; Song F; Zhang X; Liu Y
Biomed Pharmacother; 2019 Dec; 120():109231. PubMed ID: 31546082
[TBL] [Abstract][Full Text] [Related]
14. Effects of dexmedetomidine on the degree of myocardial ischemia-reperfusion injury, oxidative stress and TLR4/NF-κB signaling pathway in rats.
Liu Y; Qu X; Zhang J; Wang X; Wang J
Pak J Pharm Sci; 2021 Sep; 34(5(Special)):2047-2051. PubMed ID: 34862872
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis.
Zhang X; Li Y; Wang Y; Zhuang Y; Ren X; Yang K; Ma W; Zhong M
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406910
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats.
Hu B; Tian T; Li XT; Hao PP; Liu WC; Chen YG; Jiang TY; Chen PS; Cheng Y; Xue FS
Redox Rep; 2023 Dec; 28(1):2158526. PubMed ID: 36738240
[TBL] [Abstract][Full Text] [Related]
17. Research on protective mechanism of ibuprofen in myocardial ischemia-reperfusion injury in rats through the PI3K/Akt/mTOR signaling pathway.
Chi Y; Ma Q; Ding XQ; Qin X; Wang C; Zhang J
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4465-4473. PubMed ID: 31173323
[TBL] [Abstract][Full Text] [Related]
18. 22-oxacalcitriol protects myocardial ischemia-reperfusion injury by suppressing NF-κB/TNF-α pathway.
Zhou CN; Yao W; Gong YN; Li Y; Wang CH; Huo YF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5495-5502. PubMed ID: 31298403
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine reduces myocardial ischemia-reperfusion injury in young mice through MIF/AMPK/GLUT4 axis.
Chen S; Li A; Wu J; Huang Y; Zou T; Tailaiti T; Wang J
BMC Anesthesiol; 2022 Sep; 22(1):289. PubMed ID: 36104681
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
Zhong Y; Li YP; Yin YQ; Hu BL; Gao H
Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
